Active pharmaceutical ingredients (API) with unfavorable physicochemical properties and
stability present a significant challenge during their processing into final dosage forms …

Multicomponent solid forms of low molecular weight drugs, such as co-crystals, salts, and co-
amorphous systems, are a result of the combination of an active pharmaceutical ingredient …

In this study, the existing set of carbamazepine (CBZ) cocrystals was extended through the
successful combination of the drug with the positional isomers of acetamidobenzoic acid …

Pharmaceutical co-crystals represent a growing class of crystal forms in the context of
pharmaceutical science. They are attractive to pharmaceutical scientists because they …

The most favored approach for drug administration is the oral route. Several anticancer
drugs come under this category and mostly lack solubility and oral bioavailability, which are …

The development of multicomponent crystal forms, such as cocrystals, represents a means
to enhance the dissolution and absorption properties of poorly water-soluble drug …

Cocrystals have been extensively used to improve the physicochemical properties and
bioavailability of active pharmaceutical ingredients. Cocrystals of anti-tuberculosis …

The design and synthesis of cocrystals have emerged as promising crystal engineering
strategies for enhancing the physicochemical properties of a diverse range of target …

Bexarotene (BEX) was approved by the FDA in 1999 for the treatment of cutaneous T-cell
lymphoma (CTCL). The poor aqueous solubility causes the low bioavailability of the drug …

Roxadustat (RXD) is an approved drug substances for the treatment of renal anemia. It has
poor aqueous solubility and photochemical stability. This study employs a comprehensive …